NUTRITIONAL GROWTH SOLUTIONS LTD — Regulatory Filings 2021

Jul 7, 2021

==> picture [113 x 92] intentionally omitted <==

ASX Announcement

CLARIFICATION ANNOUNCEMENT

8 July 2021 - Nutritional Growth Solutions Ltd. (“the Company” or “NGS”, ASX:NGS) refers to the announcement titled “Healthy Height® ADHD Kids Stimulant Trial” released on the ASX Markets Announcements Platform on 5 July 2021.

NGS wishes to clarify some of the material terms of its agreement with Schneider Children’s Medical Center (the “ Agreement ”):

• The term of the Agreement is from the day of execution and until the clinical trial is either completed or terminated by either party.

• Either party may terminate the trial for good and sufficient reasons at any time subject to thirty (30) days prior written notice.

• While the trial is contingent upon the approval of the hospital’s ethics committee (Helsinki committee), such approval was already granted prior to the execution of the Agreement. Therefore, the clinical trial can commence shortly after the execution of the Agreement.

• The trial will assess the effect of 6 months of double-blind supplementation of Healthy Height® versus placebo, followed by 6-months of open label with Healthy Height® only, in prepubertal children treated with stimulants medications for ADHD.

• For each participant, the trial will include 5 visits, which will take place at 0, 3, 6, 9 ,12, months.

• While each patient will be monitored for 12 months, the total term of the study will also include the time needed to recruit all 75 participants, and additional time to analyze the results. The duration of the recruitment period and of the analysis period are not defined in the Agreement.

• The amount payable by NGS to Schneider’s in relation to the trial is immaterial to the Company, and will be paid over the course of the Trial, on a quarterly basis, and based on actual patient visits performed during the quarter.

In addition, NGS wishes to clarify, in relation to the following statement: “Healthy Height® is already clinically proven to increase height and weight in short and lean children aged three to nine years old by 13.8% – 34% to their annual growth with no increase in Body Mass Index (BMI) over a one-year period – the only nutritional supplement in the world to able to make this claim” – that the claim that Healthy Height® is the only nutritional supplement in the world able to make the said claim, is made to the best of the Company’s knowledge and based on its understanding and knowledge of the nutritional supplements market. Healthy Height® was also granted a patent in Australia and in the US based on the novelty of its formulation.

Nutritional Growth Solutions Ltd. ARBN 642 861 774 Israel: 4 Berkovich Street, Tel Aviv 6423806 Australia (Registered Local Agent): C/- Level 5, 126 Phillip Street, Sydney NSW 2000

ASX Code: NGS

www.ngsolutions.co

==> picture [113 x 92] intentionally omitted <==

-ENDS-

This announcement has been authorised for release by the Board of Directors of Nutritional Growth Solutions Ltd.

For more information:

Investors

Media

Mr Brian Leedman Tristan Everett Chairman, Nutritional Growth Solutions Market Eye +61 (0) 412 281 780 +61 403 789 096 bleedman@ngsolutions.co tristan.everett@marketeye.com.au

About Nutritional Growth Solutions

Nutritional Growth Solutions is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into pediatric nutrition at Schneider Children’s Medical Centre, Israel’s largest pediatric hospital. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The three to twelve-year-old consumers represent a larger market opportunity and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity.

ngsolutions.co

Nutritional Growth Solutions Ltd. – ASX Announcement 8 July 2021

Page 2 of 2